Abivax SA (NASDAQ:ABVX, EPA:ABVX, FRA:2X10, FRA:2X1) shares surged more than 40% on Tuesday after the French biotech released ...
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance ...
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative ...
Yuva Biosciences' proprietary MitoNova™ AI platform identified small-molecule candidates that were biologically validated in primary human ...
New data from a Phase 3 maintenance study showed malignancy rates in line with what ulcerative colitis patients normally ...
Less than a month after its stock roller-coastered on safety signals associated with its late-stage ulcerative colitis (UC) ...
These positive Phase 3 induction results for tulisokibart are the first for an anti-TL1A biologic. They represent an important step forward for patients with moderately to severely active ulcerative ...
Yes, public safety deserves attention, but the real history of this cultural center in the urban core is one of music, ...
Vashon Island Beachcomber on MSN
KC Council approves $431 million supplemental budget
The King County Council has approved a $431 million supplemental budget for the 2026-2027 season.
Abivax SA ABVX on Monday shared additional Phase 3 maintenance data for investigational ulcerative colitis therapy obefazimod ...
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 ATLAS-UC induction-only study (Study 2) evaluating tulisokibart ...
Katz noted that the IDF's current military goal in Lebanon was not to return the situation to its previous state, but to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results